Fuzan Jiaqing Long Pian (呋咱甲氢龙片)呋咱甲氢龙片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 海南制药厂有限公司制药一厂Chinese legal name: 海南制药厂有限公司制药一厂
主要成分Active Ingredients
- 夫拉扎勃Fula Zhabo
药物知识说明
夫拉扎勃是一种在国家药监局注册认定的药品。标注生产企业为海南制药厂有限公司制药一厂。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为:海南制药厂有限公司制药一厂Chinese legal name: 海南制药厂有限公司制药一厂、海南制药厂有限公司制药一厂Chinese legal name: 海南制药厂有限公司制药一厂、海南制药厂有限公司制药一厂Chinese legal name: 海南制药厂有限公司制药一厂。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 呋咱甲氢龙片) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 海南制药厂有限公司制药一厂.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 海南制药厂有限公司制药一厂Chinese legal name: 海南制药厂有限公司制药一厂, 海南制药厂有限公司制药一厂Chinese legal name: 海南制药厂有限公司制药一厂, 海南制药厂有限公司制药一厂Chinese legal name: 海南制药厂有限公司制药一厂.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 呋咱甲氢龙片Recorded Chinese name: 呋咱甲氢龙片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 1mg1 mg
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 海南制药厂有限公司制药一厂Chinese legal name: 海南制药厂有限公司制药一厂
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H41024370
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H41024370
Manufacturer
Chinese legal name: 海南制药厂有限公司制药一厂 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H41024370
生产企业
海南制药厂有限公司制药一厂(国产)
适应症
1.本品为蛋白同化激素。 2.适用于高脂血症(高胆固醇血症、高甘油三酯血症)及动脉粥样硬化病人。也可用于创伤、慢性感染、营养不良等消耗性疾病。
用法用量
口服。每次0.5~1mg,一日3次,病情缓解后,酌减为每日口服0.5~1mg,一日1次。
不良反应
1.有些患者大剂量或长期服用本品,可引起一时性血糖增高或血清氨基转移酶升高,减量或停药后,即可恢复正常。
2.偶可引起女性男性化,月经异常或浮肿。
禁忌
孕妇禁用。
注意事项
1.糖尿病患者慎用。
2.肝肾功能不全者请遵医嘱。
贮藏
遮光、密封保存
规格
1mg
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.